Forefront Analytics LLC decreased its position in shares of Mereo BioPharma Group plc (NASDAQ:MREO – Free Report) by 20.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 65,649 shares of the company’s stock after selling 17,100 shares during the […]